Canna~Fangled Abstracts Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12-Month Longitudinal Study. Phytother Res. 2020 Feb 21. doi: 10.1002/ptr.6639. Bouso JC1, Jiménez-Garrido D1, Ona G1,2, Woźnica D1,…Freedom WaresFebruary 21, 2020
Canna~Fangled Abstracts Decreased sensitivity in adolescent versus adult rats to the antidepressant-like effects of cannabidiol. Psychopharmacology (Berl). 2020 Feb 21. doi: 10.1007/s00213-020-05481-4. Bis-Humbert C1,2, García-Cabrerizo R1,2,3, García-Fuster MJ4,5. Author information…Freedom WaresFebruary 21, 2020
Canna~Fangled Abstracts Cannabidiol for the treatment of psychosis among patients with schizophrenia and other primary psychotic disorders: A systematic review with a risk of bias assessment. Psychiatry Res. 2020 Feb 21;286:112890. doi: 10.1016/j.psychres.2020.112890. Ghabrash MF1, Coronado-Montoya S2, Aoun J1, Gagné AA1,…Freedom WaresFebruary 21, 2020
Canna~Fangled Abstracts The viability of a standard THC unit Commentary Free Access Francesca M. Filbey First published: 05 February 2020 https://doi.org/10.1111/add.14961 SECTIONS PDF TOOLS…Freedom WaresFebruary 21, 2020
Canna~Fangled Abstracts Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products. Int J Drug Policy. 2020 Feb 21;77:102688. doi: 10.1016/j.drugpo.2020.102688. Tran T1, Kavuluru R2. Author information…Freedom WaresFebruary 21, 2020
Canna~Fangled Abstracts Safety Assessment of a Hemp Extract using Genotoxicity and Oral Repeat-Dose Toxicity Studies in Sprague-Dawley Rats. Toxicol Rep. 2020 Feb 20;7:376-385. doi: 10.1016/j.toxrep.2020.02.014. eCollection 2020. Dziwenka M1, Coppock R2, Alexander M3,…Freedom WaresFebruary 20, 2020
Canna~Fangled Abstracts A new biosensor for stilbenes and a cannabinoid enabled by genome mining of a transcriptional regulator. ACS Synth Biol. 2020 Feb 20. doi: 10.1021/acssynbio.9b00443. Sun H, Zhao H, Ang EL. Abstract…Freedom WaresFebruary 20, 2020
Canna~Fangled Abstracts Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain. Int J Mol Sci. 2020 Feb 20;21(4). pii: E1423. doi: 10.3390/ijms21041423. Hossain MZ1, Ando H2,…Freedom WaresFebruary 20, 2020
Canna~Fangled Abstracts Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis. Clin Med Insights Arthritis Musculoskelet Disord. 2020 Feb 19;13:1179544120906461. doi: 10.1177/1179544120906461. eCollection 2020. Johal H1,…Freedom WaresFebruary 19, 2020
Canna~Fangled Abstracts Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review. Front Cell Neurosci. 2020 Feb 19;14:34. doi: 10.3389/fncel.2020.00034. eCollection 2020. Mecha M1, Carrillo-Salinas FJ2, Feliú…Freedom WaresFebruary 19, 2020